MIP podcasts

MIP podcasts

By MIPBusiness
Download on the App Store

MIP podcasts episodes

  • Awards podcast: Pons IP talks blockchain and AI

    In the first podcast profiling winners of Managing IP’s 2021 awards, we speak to Pons IP about the impact of technology on IP legal services

    Lawyers must become increasingly tech-savvy as artificial intelligence and other technologies make their mark on the IP legal services industry, a Managing IP podcast heard. 

    Managing editor Ed Conlon sat down with counsel at Pons IP and blockchain specialist Signeblock to discuss the future of technology in IP protection. He was joined by Pons IP of counsel Jose Carlos Erdozain and international affairs director Isabel Cortés, as well as Signeblock CEO Marta Gutiérrez. 

    Pons IP recently won the Trademark Prosecution (Patent & Trademark Attorney Firms) Firm of the Year award for Spain. The awards ceremony was conducted virtually this year. 

    25 min
  • Podcast: BMS and Bird & Bird on doing major deals in a pandemic

    In the last 10 months, we have all become accustomed to working remotely and doing things differently. For lawyers, one of the impacts has been on major deals, particularly those with a cross-jurisdictional focus.

    In Managing IP’s latest podcast, panellists from Bristol Myers Squibb and Bird & Bird share their thoughts on whether efficiency has increased, if we have said goodbye to paper for good, and whether we are in a licensor or licensee market. 

    To learn more about completing deals in a pandemic, and for a preview of the year ahead, check out our 40-minute podcast by clicking on the link above. 

    40 min
  • Podcast: fighting counterfeits in Latin America and Caribbean

    In Managing IP’s first LATAM and Caribbean podcast, Americas editor Patrick Wingrove speaks to Virginia Cervieri, co-founder at Cervieri Monsuárez in Uruguay, André Oliveira, partner at Daniel Law in Brazil, and Mikhail Jackson, partner at Livingston Alexander & Levy in Jamaica about anti-counterfeiting.

    57 min
  • Podcast: Nokia, Audi and Bird & Bird debate FRAND

    Richard Vary, Clemens Heusch and Matthias Schneider reveal their views on component-level versus end-point licensing and Unwired Planet 

    In the first of three Bird & Bird-sponsored podcasts, Americas editor Patrick Wingrove spoke to Richard Vary at Bird & Bird, Clemens Heusch at Nokia and Matthias Schneider at Audi about standard essential patent licensing. 

    Here, Vary, Heusch and Schneider debate issues of fair, reasonable and non-discriminatory terms in the context of component-level versus end-point licensing and the recent UK Supreme Court decision in Unwired Planet v Huawei. 

    We would like to thank Bird & Bird for making this podcast possible and for lending the necessary expertise in this matter. 

    To discuss the details of this episode and find out how Bird & Bird can make the most of your IP portfolio, please contact Richard Vary. 

    41 min
  • Podcast: watch brands ask if Amazon is a friend or foe

    For the latest Managing IP podcast, Max Walters was joined by IP counsel at watch companies CLUSE and Daniel Wellington, as well as a former counsel at Italian fashion brand Bulgari. 

    Guests discussed the unique challenges watch-owners face in the fight against counterfeiters, how to observe and enforce their rights on social media and e-commerce sites, and whether legislation is long overdue. Guests also discussed the role that China, and in particular Chinese e-commerce platforms, are playing to help brands.

    50 min
  • MIP's Charlotte Kilpatrick talks to Corey Salsberg of Novartis, Ellen t’Hoen of Medicines Law and Policy, and David Rosenberg formerly of GSK to discuss how COVID-19 is reshaping IP in the life sciences.

    Charlotte Kilpatrick, reporter at Managing IP, sat down with Corey Salsberg of Novartis, Ellen t’Hoen of Medicines Law and Policy, and David Rosenberg formerly of GSK, to discuss how COVID-19 is reshaping the IP landscape in the life sciences industries. The guests debated IP issues including access to medicine, open science, and the role patent and technology pooling can play to accelerate vaccine research.

    49 min

About MIP podcasts

From the publisher's feed

Multimedia content brought to you by Managing IP, the leading intellectual property publication.